AAMU
EDIT icon

Amundi Asset Management US’s Editas Medicine EDIT Stock Holding History

Amundi Asset Management US’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4,800
Closed -$109 – 1648
2018
Q4 		$109 Buy
+4,800
New +$131K ﹤0.01% 1493
2018
Q3 		– Sell
-22,200
Closed -$795K – 1616
2018
Q2 		$795K Buy
+22,200
New +$786K ﹤0.01% 1289

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

Amundi Asset Management US's EDIT Position: Q1 2019 in Review

Amundi Asset Management US sold out of Editas Medicine (EDIT) in Q1 2019, closing a stake of 4,800 shares — an estimated $109 sold.

Amundi Asset Management US first reported a position in EDIT in Q2 2018 and held it in 2 quarters. The position peaked at $795K in Q2 2018. 201 funds tracked by Wall St. Rank hold EDIT as of Q1 2019.

  • Amundi Asset Management US reported no remaining Editas Medicine position as of Q1 2019 after selling out during the quarter.
  • Amundi Asset Management US sold 4,800 Editas Medicine shares in Q1 2019, an estimated $109.
  • Amundi Asset Management US first reported a position in Editas Medicine in Q2 2018 and held it in 2 quarters.
  • Amundi Asset Management US's Editas Medicine position peaked at $795K in Q2 2018.
  • 201 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2019.

Based on Amundi Asset Management US's 13F filing for Q1 2019, filed 13 May 2019.